Obwohl die Krankheit seit 700 Jahren bekannt ist, bleibt ihre Ursache bis heute unbekannt, und entgegen der Erwartungen die Entwicklung von Bereichen wie Molekularbiologie und Immunologie macht die Situation noch komplexer.. Obwohl immer mehr Antikörper entdeckt werden, die mit dieser Krankheit verbunden sind, zeigt sich, dass sie nicht einzigartig für diese Einheit sind.
Systemic lupus erythematosus (SLE): conceptual framework, pathophysiological mechanisms, and immunological diagnostic complexities
Systemic lupus erythematosus (SLE) constitutes a complex, chronic autoimmune disorder characterized by systemic inflammation arising from dysregulated immune responses targeting the body’s own connective tissues. While patients with SLE consistently exhibit a broad array of autoantibodies—including antinuclear antibodies (ANA), anti-double-stranded DNA (anti-dsDNA), anti-Smith (anti-Sm), and antiphospholipid antibodies—none of these markers demonstrate absolute specificity for the disease, thereby complicating definitive serological diagnosis. A pivotal observational milestone in unraveling the immunopathogenesis of SLE was the phenomenon of false-positive results in nontreponemal syphilis tests (e.g., VDRL), attributable to cross-reactivity between anticardiolipin antibodies and the lipid antigens employed in these assays. Persistence of such false-positive reactions for a minimum of six months may serve as a clinically significant indicator suggestive of SLE. Despite advances in identifying risk factors (genetic, environmental, hormonal) and elucidating the inflammatory cascade leading to organ damage, the etiopathogenesis of SLE remains incompletely understood. Contemporary medicine continues to seek answers to fundamental questions regarding the initiation of the disease process and its primary molecular and cellular underpinnings.
Sie haben begonnen, einen PRO-Artikel zu lesen
Sie können das erste Kapitel lesen. Um den gesamten Artikel zu lesen und alle Inhalte freizuschalten, wechseln Sie zum PRO-Konto.